Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma
ClinicalTrials.gov study NCT00276055. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors
ClinicalTrials.gov study NCT00054288. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
ClinicalTrials.gov study NCT00243100. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients
ClinicalTrials.gov study NCT06374914. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer
ClinicalTrials.gov study NCT01405586. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT06576115. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment
ClinicalTrials.gov study NCT00288925. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer
ClinicalTrials.gov study NCT00486460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas
ClinicalTrials.gov study NCT00179751. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00660231. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations
GEO Series GSE232549. Homo sapiens. 26 samples. Type: Expression profiling by high throughput sequencing.
The effect of Gemcitabine chemotherapy on lung intertiatial macrophages (IMs) from tumor-free mice
GEO Series GSE217105. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Cadherin 11 promotes immunosuppression and extracellular matrix deposition to promote growth of pancreatic tumors and resistance to gemcitabine in mice
GEO Series GSE157781. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
Nrf2 depletion sensitizes pancreatic cancer cells to gemcitabine via aldehyde dehydrogenase 3a1 repression.
GEO Series GSE172046. Mus musculus. 4 samples. Type: Expression profiling by array.
Targeting cancer-associated fibroblast-mediated LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer
GEO Series GSE300401. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
Activated stroma dictates response to gemcitabine in combination with nab-paclitaxel in pancreatic ductal adenocarcinoma patient derived xenografts (PDAC-PDX).
GEO Series GSE234259. Homo sapiens; Mus musculus. 15 samples. Type: Expression profiling by array.
Time-course analysis to characterize the molecular mechanisms for 5637 gemcitabine-resistant cancer (5637GRC) cell line
GEO Series GSE210954. Homo sapiens. 31 samples. Type: Expression profiling by high throughput sequencing.
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: A randomized, multi-arm, phase I trial
GEO Series GSE313748. Homo sapiens. 724 samples. Type: Other.
Drug-induced change in gene expression across NCI-60 cell lines after exposure to 15 anticancer agents for 2, 6 and 24h (gemcitabine)
GEO Series GSE116444. Homo sapiens. 495 samples. Type: Expression profiling by array.
Effects of a quadruplex-binding compound on gemcitabine resistant pancreatic cancer cells
GEO Series GSE148200. Homo sapiens. 18 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.